Insufficient scRNA-seq data for expression of SLC26A5 at single-cell level.
Insufficient scRNA-seq data for expression of SLC26A5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 85.48 | 240 / 245 | 57% | 1.36 | 285 / 502 |
lung | 99% | 51.14 | 571 / 578 | 17% | 0.43 | 201 / 1155 |
breast | 99% | 118.67 | 453 / 459 | 14% | 0.28 | 151 / 1118 |
thymus | 100% | 102.08 | 652 / 653 | 9% | 0.16 | 54 / 605 |
adrenal gland | 84% | 22.26 | 216 / 258 | 16% | 0.29 | 37 / 230 |
stomach | 92% | 48.88 | 330 / 359 | 5% | 0.09 | 15 / 286 |
uterus | 86% | 22.19 | 146 / 170 | 8% | 0.15 | 36 / 459 |
adipose | 92% | 34.56 | 1105 / 1204 | 0% | 0 | 0 / 0 |
spleen | 90% | 33.03 | 216 / 241 | 0% | 0 | 0 / 0 |
kidney | 83% | 25.21 | 74 / 89 | 1% | 0.02 | 8 / 901 |
ovary | 83% | 20.38 | 149 / 180 | 1% | 0.03 | 5 / 430 |
bladder | 76% | 136.33 | 16 / 21 | 7% | 0.17 | 33 / 504 |
skin | 77% | 59.39 | 1401 / 1809 | 1% | 0.02 | 3 / 472 |
intestine | 75% | 16.38 | 724 / 966 | 2% | 0.07 | 11 / 527 |
blood vessel | 75% | 18.22 | 997 / 1335 | 0% | 0 | 0 / 0 |
liver | 72% | 18.62 | 162 / 226 | 0% | 0.01 | 2 / 406 |
esophagus | 54% | 9.91 | 782 / 1445 | 16% | 0.33 | 30 / 183 |
pancreas | 60% | 11.07 | 198 / 328 | 1% | 0.02 | 2 / 178 |
brain | 57% | 43.67 | 1500 / 2642 | 0% | 0 | 0 / 705 |
heart | 35% | 6.84 | 301 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 21% | 4.00 | 198 / 929 | 0% | 0 | 0 / 0 |
muscle | 20% | 3.49 | 163 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.09 | 3 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007605 | Biological process | sensory perception of sound |
GO_0010996 | Biological process | response to auditory stimulus |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0002931 | Biological process | response to ischemia |
GO_0035864 | Biological process | response to potassium ion |
GO_0006821 | Biological process | chloride transport |
GO_0097066 | Biological process | response to thyroid hormone |
GO_0019532 | Biological process | oxalate transport |
GO_2000147 | Biological process | positive regulation of cell motility |
GO_0015755 | Biological process | fructose transmembrane transport |
GO_1902074 | Biological process | response to salt |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0090102 | Biological process | cochlea development |
GO_1902358 | Biological process | sulfate transmembrane transport |
GO_0034766 | Biological process | negative regulation of monoatomic ion transmembrane transport |
GO_0008360 | Biological process | regulation of cell shape |
GO_0045793 | Biological process | positive regulation of cell size |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0015701 | Biological process | bicarbonate transport |
GO_0009751 | Biological process | response to salicylic acid |
GO_0005886 | Cellular component | plasma membrane |
GO_0120249 | Cellular component | lateral wall of outer hair cell |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019531 | Molecular function | oxalate transmembrane transporter activity |
GO_0015116 | Molecular function | sulfate transmembrane transporter activity |
GO_0030507 | Molecular function | spectrin binding |
GO_0015106 | Molecular function | bicarbonate transmembrane transporter activity |
GO_0008271 | Molecular function | secondary active sulfate transmembrane transporter activity |
GO_0015108 | Molecular function | chloride transmembrane transporter activity |
GO_0140900 | Molecular function | chloride:bicarbonate antiporter activity |
Gene name | SLC26A5 |
Protein name | Solute carrier family 26 member 5 SLC26A5 protein (Solute carrier family 26 member 5) Prestin (Solute carrier family 26 member 5) |
Synonyms | PRES |
Description | FUNCTION: Voltage-sensitive motor protein that drives outer hair cell (OHC) electromotility (eM) and participates in sound amplification in the hearing organ (By similarity). Converts changes in the transmembrane electric potential into mechanical displacements resulting in the coupling of its expansion to movement of a charged voltage sensor across the lipid membrane (By similarity). The nature of the voltage sensor is not completely clear, and two models compete. In the first model, acts as an incomplete transporter where intracellular chloride anion acts as extrinsic voltage sensor that drives conformational change in the protein which is sufficient to produce a length change in the plane of the membrane and hence in the length of the OHC (By similarity). The second model in which multiple charged amino acid residues are distributed at the intracellular and extracellular membrane interfaces that form an intrinsic voltage sensor, whose movement produces the non-linear capacitance (NLC) . However, the effective voltage sensor may be the result of a hybrid voltage sensor, assembled from intrinsic charge (charged residues) and extrinsic charge (bound anion) (By similarity). Notably, binding of anions to the anion-binding pocket partially neutralizes the intrinsic positive charge rather than to form an electrically negative sensor, therefore remaining charge may serve as voltage sensor that, after depolarization, moves from down (expanded state) to up (contracted) conformation, which is accompanied by an eccentric contraction of the intermembrane cross-sectional area of the protein as well as a major increase in the hydrophobic thickness of the protein having as consequences the plasma membrane thickening and the cell contraction after membrane depolarization . The anion-binding pocket transits from the inward-open (Down) state, where it is exposed toward the intracellular solvent in the absence of anion, to the occluded (Up) state upon anion binding . Salicylate competes for the anion-binding site and inhibits the voltage-sensor movement, and therefore inhibits the charge transfer and electromotility by displacing Cl(-) from the anion-binding site and by preventing the structural transitions to the contracted state . In addition, can act as a weak Cl(-)/HCO3(-) antiporter across the cell membrane and so regulate the intracellular pH of the outer hair cells (OHCs), while firstly found as being unable to mediate electrogenic anion transport (By similarity). Moreover, supports a role in cardiac mechanical amplification serving as an elastic element to enhance the actomyosin- based sarcomere contraction system (By similarity). . FUNCTION: Voltage-sensitive motor protein that drives outer hair cell (OHC) electromotility (eM) and participates in sound amplification in the hearing organ. Converts changes in the transmembrane electric potential into mechanical displacements resulting in the coupling of its expansion to movement of a charged voltage sensor across the lipid membrane. The nature of the voltage sensor is not completely clear, and two models compete. In the first model, acts as an incomplete transporter where intracellular chloride anion acts as extrinsic voltage sensor that drives conformational change in the protein which is sufficient to produce a length change in the plane of the membrane and hence in the length of the OHC. The second model in which multiple charged amino acid residues are distributed at the intracellular and extracellular membrane interfaces that form an intrinsic voltage sensor, whose movement produces the non-linear capacitance (NLC). However, the effective voltage sensor may be the result of a hybrid voltage sensor, assembled from intrinsic charge (charged residues) and extrinsic charge (bound anion). Notably, binding of anions to the anion-binding pocket partially neutralizes the intrinsic positive charge rather than to form an electrically negative sensor, therefore remaining charge may serve as voltage sensor that, after depolarization, moves from down (expanded state) to up (contracted) conformation, which is accompanied by an eccentric contraction of the intermembrane cross-sectional area of the protein as well as a major increase in the hydrophobic thickness of the protein having as consequences the plasma membrane thickening and the cell contraction after membrane depolarization. The anion-binding pocket transits from the inward-open (Down) state, where it is exposed toward the intracellular solvent in the absence of anion, to the occluded (Up) state upon anion binding. Salicylate competes for the anion-binding site and inhibits the voltage-sensor movement, and therefore inhibits the charge transfer and electromotility by displacing Cl(-) from the anion-binding site and by preventing the structural transitions to the contracted state. In addition, can act as a weak Cl(-)/HCO3(-) antiporter across the cell membrane and so regulate the intracellular pH of the outer hair cells (OHCs), while firstly found as being unable to mediate electrogenic anion transport. Moreover, supports a role in cardiac mechanical amplification serving as an elastic element to enhance the actomyosin- based sarcomere contraction system. . FUNCTION: Voltage-sensitive motor protein that drives outer hair cell (OHC) electromotility (eM) and participates in sound amplification in the hearing organ. Converts changes in the transmembrane electric potential into mechanical displacements resulting in the coupling of its expansion to movement of a charged voltage sensor across the lipid membrane. The nature of the voltage sensor is not completely clear, and two models compete. In the first model, acts as an incomplete transporter where intracellular chloride anion acts as extrinsic voltage sensor that drives conformational change in the protein which is sufficient to produce a length change in the plane of the membrane and hence in the length of the OHC. The second model in which multiple charged amino acid residues are distributed at the intracellular and extracellular membrane interfaces that form an intrinsic voltage sensor, whose movement produces the non-linear capacitance (NLC). However, the effective voltage sensor may be the result of a hybrid voltage sensor, assembled from intrinsic charge (charged residues) and extrinsic charge (bound anion). Notably, binding of anions to the anion-binding pocket partially neutralizes the intrinsic positive charge rather than to form an electrically negative sensor, therefore remaining charge may serve as voltage sensor that, after depolarization, moves from down (expanded state) to up (contracted) conformation, which is accompanied by an eccentric contraction of the intermembrane cross-sectional area of the protein as well as a major increase in the hydrophobic thickness of the protein having as consequences the plasma membrane thickening and the cell contraction after membrane depolarization. The anion-binding pocket transits from the inward-open (Down) state, where it is exposed toward the intracellular solvent in the absence of anion, to the occluded (Up) state upon anion binding. Salicylate competes for the anion-binding site and inhibits the voltage-sensor movement, and therefore inhibits the charge transfer and electromotility by displacing Cl(-) from the anion-binding site and by preventing the structural transitions to the contracted state. In addition, can act as a weak Cl(-)/HCO3(-) antiporter across the cell membrane and so regulate the intracellular pH of the outer hair cells (OHCs), while firstly found as being unable to mediate electrogenic anion transport. Moreover, supports a role in cardiac mechanical amplification serving as an elastic element to enhance the actomyosin- based sarcomere contraction system. . |
Accessions | Q496J1 Q496J0 ENST00000393730.5 [P58743-5] P58743 ENST00000306312.8 [P58743-1] ENST00000393729.5 ENST00000445809.5 ENST00000393723.2 [P58743-6] ENST00000393735.6 [P58743-3] ENST00000423416.5 ENST00000393727.5 F8WDL4 E9PCM2 F8WD50 ENST00000432958.6 [P58743-5] ENST00000454864.5 ENST00000356767.8 [P58743-4] Q496J3 ENST00000339444.10 [P58743-2] Q7Z7F4 ENST00000456463.5 |